Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-08-20 00:00:00 ET · period of report 2025-08-18 · accession 0001819879-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-08-20 | 2025-08-18 | ANIP | Thoma Jeanne | Dir | S - Sale | $89.15 | -21.5K | 23.4K | -48% | -$1.92M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-18 | S | D | 6,865 | $89.76 | 38,080 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $89.75 to $89.90. The price reported above reflects the weighted average sales price. |
| 2 | Common | Common Stock | 2025-08-18 | S | D | 14,675 | $88.87 | 23,405 | D | — | — | (F2) The shares were sold in multiple trades at prices ranging from $88.74 to $89.39. The price reported above reflects the weighted average sales price. |